Furthermore, treatment with a “next-generation” selective SIK2/SIK3 inhibitor stimulated Cyp27b1 expression and 1,25-(OH)2 vitamin D production, even in the setting of chronic kidney disease. The gene discussed is CYP27B1; the disease is chronic kidney disease.